GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1

NCT00123578 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to recruit adaquate number of GHB dependent subjects

Conditions

Substance-Related Disorders

Interventions

DRUG: Lorazepam
DRUG: Pentobarbital

Sponsor

University of California, Los Angeles

Collaborators

[object Object]